Amanta Healthcare Limited has informed the Exchange regarding a press release dated May 19, 2026, titled "Amanta Healthcare Limited announcesQ4 & FY26 Results".

AMANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-4.7%1-day move

₹132.00

prior close

₹131.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.1-1.9-1.5-2.3-4.7-1.5-0.8+1.3+0.2-8.3+12.6+21.6+24.7—

Up moveDown movePending

AI summary

Amanta Healthcare reported Q4FY26 revenue of ₹77 crore (up 7% YoY) and FY26 revenue of ₹288 crore (up 5% YoY). PAT grew strongly with Q4FY26 PAT at ₹5.5 crore (up 28% YoY) and FY26 PAT at ₹15 crore (up 42% YoY), driven by lower finance costs and improved operating leverage. EBITDA margins remained stable at 22% for FY26. The company is expanding capacity for high-margin SteriPort and SVP products, with plans to grow both domestic and export markets. A captive solar power project is underway to improve operational efficiency.

Likely market impact

Strong profitability growth with 42% YoY PAT increase and maintained margins indicate effective cost control and operational efficiency, which could positively influence investor sentiment.